EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication

Christina A Higgins, Benjamin E Nilsson-Payant iD, Boris Bonaventure, Andrew P Kurland, Chengjin Ye iD, Tomer M Yaron, Jared L Johnson, Prithy Adhikary, Ilona Golynker, Maryline Panis, Oded Danziger, Brad R Rosenberg iD und 4 weitere

mBio · 22.06.2023

DOI: 10.1128/mbio.01007-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, online erschienen am 22.06.2023. Verfasst von Christina A Higgins und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, drastically modifies infected cells to optimize virus replication. One such modification is the activation of the host p38 mitogen-activated protein kinase (MAPK) pathway, which plays a major role in inflammatory cytokine production, a hallmark of severe COVID-19. We previously demonstrated that inhibition of p38/MAPK activity in SARS-CoV-2-infected cells reduced both cytokine production and viral replication. Here, we combined quantitative genetic screening, genomics, proteomics, and phosphoproteomics to better understand mechanisms underlying the dependence of SARS-CoV-2 on the p38 pathway. We found that p38β is a critical host factor for SARS-CoV-2 replication in multiple relevant cell lines and that it functions at a step after viral mRNA expression. We identified putative host and viral p38β substrates in the context of SARS-CoV-2 infection and found that most host substrates have intrinsic antiviral activities. Taken together, this study reveals a unique proviral function for p38β and supports exploring p38β inhibitor development as a strategy toward creating a new class of COVID-19 therapies. IMPORTANCE SARS-CoV-2 is the causative agent of the COVID-19 pandemic that has claimed millions of lives since its emergence in 2019. SARS-CoV-2 infection of human cells requires the activity of several cellular pathways for successful replication. One such pathway, the p38 MAPK pathway, is required for virus replication and disease pathogenesis. Here, we applied systems biology approaches to understand how MAPK pathways benefit SARS-CoV-2 replication to inform the development of novel COVID-19 drug therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansCytokinesp38 Mitogen-Activated Protein KinasesPandemicsVirus ReplicationMitogen-Activated Protein Kinase 11

Stichwörter der Autor:innen

MAPK11SARS-CoV-2p38 kinasesp38βphosphoproteomicsproteomics

Substanzen

Cytokinesp38 Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase 11

Autor:innen und Institutionen

  • Department of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
  • Department of Microbiology, New York University Langone Health , New York, New York, USA.
  • Vilcek Graduate School for Biomedical Sciences, New York University Langone Health , New York, New York, USA.
  • Texas Biomedical Research Institute , San Antonio, Texas, USA.
  • Meyer Cancer Center, Weill Cornell Medicine , New York, New York, USA.

ORCID-Profile: Benjamin E Nilsson-Payant, Chengjin Ye, Brad R Rosenberg, Luis Martínez-Sobrido, Benjamin tenOever, Jeffrey R Johnson

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Higgins, C. A., Nilsson-Payant, B. E., Bonaventure, B., Kurland, A. P., Ye, C., Yaron, T. M., Johnson, J. L., Adhikary, P., Golynker, I., Panis, M., Danziger, O., Rosenberg, B. R., Cantley, L. C., Martínez-Sobrido, L., tenOever, B., & Johnson, J. R. (2023). SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. mBio. https://doi.org/10.1128/mbio.01007-23

Vancouver

Higgins CA, Nilsson-Payant BE, Bonaventure B, Kurland AP, Ye C, Yaron TM, et al. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication. mBio. 2023. doi:10.1128/mbio.01007-23

BibTeX
@article{Higgins2023,
  author = {Higgins, Christina A and Nilsson-Payant, Benjamin E and Bonaventure, Boris and Kurland, Andrew P and Ye, Chengjin and Yaron, Tomer M and Johnson, Jared L and Adhikary, Prithy and Golynker, Ilona and Panis, Maryline and Danziger, Oded and Rosenberg, Brad R and Cantley, Lewis C and Martínez-Sobrido, Luis and tenOever, Benjamin and Johnson, Jeffrey R},
  title = {SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.01007-23}
}
Kostenlos starten →